Preimplantation Genetic Diagnosis (PGD)

Preimplantation Genetic Diagnosis (PGD) is a reproductive technology used to screen embryos for genetic abnormalities before they are implanted in the uterus during in vitro fertilization (IVF). PGD enables couples at risk of passing on genetic disorders to conceive embryos that are free from the specific genetic condition they carry. It also raises complex ethical considerations related to embryo selection, non-medical applications, access to care, and reproductive autonomy.

Applications of Preimplantation Genetic Diagnosis (PGD) includes

  • Prevention of genetic disorders
  • Family balancing
  • Reduced risk of genetic disorders
  • Increased pregnancy success rates

 

    Related Conference of Preimplantation Genetic Diagnosis (PGD)

    August 28-29, 2025

    12th World Congress on Epigenetics and Chromosome

    London, UK
    September 16-17, 2025

    5th Experts Meeting on Plant, Cellular and Molecular Biology

    Madrid, Spain
    September 25-26, 2025

    18th World Congress on Advances in Stem Cell Research and Regenerative Medicine

    Montreal, Canada
    October 27-28, 2025

    20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Madrid, Spain
    October 30-31, 2025

    Annual Congress on CRISPR Cas9 Technology and Genetic Engineering

    Rome, Italy
    November 17-18, 2025

    18th International Conference on Human Genomics and Genomic Medicine

    Paris, France
    June 18-19, 2026

    16th International Conference on Human Genetics and Genetic Diseases

    Singapore City, Singapore
    June 18-19, 2026

    19th International Conference on Genomics & Pharmacogenomics

    Singapore City, Singapore
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Preimplantation Genetic Diagnosis (PGD) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in